Join Growin Stock Community!
Beta
Back to NBIS.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
operating-expenses-chart

NBIS Operating Expenses

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

As of the latest data point in Q1'26, the total operating expenses reached 211.2M USD, driven by 143.8M USD in SG&A Expenses and 67.4M USD in R&D Expenses. This represents a significant shift in the cost structure compared to the previous quarter, with R&D reaching its highest level since the beginning of FY2024. From Q2'23 to Q1'26, the data displays a dramatic decline in total operating expenses following Q4'23, where SG&A and R&D peaked at 988.6M USD and 335.9M USD respectively. Since Q1'24, expenses have stabilized at a lower base but have trended steadily upward over the last five quarters, with SG&A consistently remaining the dominant component of the expenditure. Notably, R&D Expenses have nearly doubled from 34.4M USD in Q3'24 to 67.4M USD in Q1'26, indicating an increasing focus on product development.